BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 27110040)

  • 61. Impact of inherited polymorphisms in glutathione S-transferase M1, microsomal epoxide hydrolase, cytochrome P450 enzymes on DNA, and blood protein adducts of benzo(a)pyrene-diolepoxide.
    Pastorelli R; Guanci M; Cerri A; Negri E; La Vecchia C; Fumagalli F; Mezzetti M; Cappelli R; Panigalli T; Fanelli R; Airoldi L
    Cancer Epidemiol Biomarkers Prev; 1998 Aug; 7(8):703-9. PubMed ID: 9718223
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Depression of hepatic cytochrome P450 monooxygenases after chronic environmental tobacco smoke exposure of young ferrets.
    Sindhu RK; Rasmussen RE; Yamamoto R; Fujita I; Kikkawa Y
    Toxicol Lett; 1995 Apr; 76(3):227-38. PubMed ID: 7762009
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cytochrome P450 system expression and DNA adduct formation in the liver of Zacco platypus following waterborne benzo(a)pyrene exposure: implications for biomarker determination.
    Lee JW; Kim YH; Yoon S; Lee SK
    Environ Toxicol; 2014 Sep; 29(9):1032-42. PubMed ID: 23192953
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The first identification of the benzenediazonium ion formation from a non-aminoazo dye, 1-phenylazo-2-hydroxynaphthalene (Sudan I) by microsomes of rat livers.
    Stiborová M; Asfaw B; Anzenbacher P; Leseticky L; Hodek P
    Cancer Lett; 1988 Jun; 40(3):319-26. PubMed ID: 3383183
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Metabolism of benzo[a]pyrene to trans-7,8-dihydroxy-7, 8-dihydrobenzo[a]pyrene by recombinant human cytochrome P450 1B1 and purified liver epoxide hydrolase.
    Shimada T; Gillam EM; Oda Y; Tsumura F; Sutter TR; Guengerich FP; Inoue K
    Chem Res Toxicol; 1999 Jul; 12(7):623-9. PubMed ID: 10409402
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Rat microsomes activating the anticancer drug ellipticine to species covalently binding to deoxyguanosine in DNA are a suitable model mimicking ellipticine bioactivation in humans.
    Stiborová M; Stiborová-Rupertová M; Borek-Dohalská L; Wiessler M; Frei E
    Chem Res Toxicol; 2003 Jan; 16(1):38-47. PubMed ID: 12693029
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Role of cytochromes P450 in metabolism of carcinogenic aristolochic acid I: evidence of their contribution to aristolochic acid I detoxication and activation in rat liver.
    Stiborova M; Mares J; Levova K; Pavlickova J; Barta F; Hodek P; Frei E; Schmeiser HH
    Neuro Endocrinol Lett; 2011; 32 Suppl 1():121-30. PubMed ID: 22167220
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Modifications of carcinogen metabolism in hepatic microsomes of suckling young by 3-methylcholanthrene or beta-naphthoflavone administered to lactating rats.
    Malejka-Giganti D; Decker RW; Ritter CL
    Biochem Pharmacol; 1983 Nov; 32(22):3335-44. PubMed ID: 6316979
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Beta carotene and its oxidation products have different effects on microsome mediated binding of benzo[a]pyrene to DNA.
    Salgo MG; Cueto R; Winston GW; Pryor WA
    Free Radic Biol Med; 1999 Jan; 26(1-2):162-73. PubMed ID: 9890651
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Inhibition of aryl hydrocarbon receptor transactivation and DNA adduct formation by CYP1 isoform-selective metabolic deactivation of benzo[a]pyrene.
    Endo K; Uno S; Seki T; Ariga T; Kusumi Y; Mitsumata M; Yamada S; Makishima M
    Toxicol Appl Pharmacol; 2008 Jul; 230(2):135-43. PubMed ID: 18372000
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Tumor necrosis factor-alpha potentiates genotoxic effects of benzo[a]pyrene in rat liver epithelial cells through upregulation of cytochrome P450 1B1 expression.
    Umannová L; Machala M; Topinka J; Nováková Z; Milcová A; Kozubík A; Vondrácek J
    Mutat Res; 2008 Apr; 640(1-2):162-9. PubMed ID: 18336843
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Benzo[g,h,i]perylene synergistically transactivates benzo[a]pyrene-induced CYP1A1 gene expression by aryl hydrocarbon receptor pathway.
    Cherng SH; Lin P; Yang JL; Hsu SL; Lee H
    Toxicol Appl Pharmacol; 2001 Jan; 170(1):63-8. PubMed ID: 11141357
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Induction of cytochromes P450 1A1 and 1A2 suppresses formation of DNA adducts by carcinogenic aristolochic acid I in rats in vivo.
    Dračínská H; Bárta F; Levová K; Hudecová A; Moserová M; Schmeiser HH; Kopka K; Frei E; Arlt VM; Stiborová M
    Toxicology; 2016 Feb; 344-346():7-18. PubMed ID: 26845733
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Metabolic activation of racemic and enantiomeric trans-8, 9-dihydroxy-8,9-dihydrodibenzo[a,l]pyrene (dibenzo[def,p]chrysene) to dibenzo[a,l]pyrene-bis-dihydrodiols by induced rat liver microsomes and a recombinant human P450 1A1 system: the role of the K-region-derived metabolic intermediates in the formation of dibenzo[a,l]pyrene-DNA adducts.
    Nesnow S; Davis C; Padgett W; George M; Lambert G; Meyers F; Allison J; Adams L; King LC
    Chem Res Toxicol; 1998 Dec; 11(12):1596-607. PubMed ID: 9860506
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Human hepatic and renal microsomes, cytochromes P450 1A1/2, NADPH:cytochrome P450 reductase and prostaglandin H synthase mediate the formation of aristolochic acid-DNA adducts found in patients with urothelial cancer.
    Stiborová M; Frei E; Hodek P; Wiessler M; Schmeiser HH
    Int J Cancer; 2005 Jan; 113(2):189-97. PubMed ID: 15386410
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Inhibitory effects of chrysoeriol on DNA adduct formation with benzo[a]pyrene in MCF-7 breast cancer cells.
    Takemura H; Nagayoshi H; Matsuda T; Sakakibara H; Morita M; Matsui A; Ohura T; Shimoi K
    Toxicology; 2010; 274(1-3):42-8. PubMed ID: 20553787
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Induction of CYP1A1 and CYP1B1 in T-47D human breast cancer cells by benzo[a]pyrene is diminished by arsenite.
    Spink DC; Katz BH; Hussain MM; Spink BC; Wu SJ; Liu N; Pause R; Kaminsky LS
    Drug Metab Dispos; 2002 Mar; 30(3):262-9. PubMed ID: 11854143
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effect of dihydromyricetin on benzo[a]pyrene activation in rats.
    Hodek P; Fousova P; Brabencova E; Moserova M; Pavek P; Anzenbacherova E; Brotanek J; Hudecek J; Frei E; Stiborova M
    Neuro Endocrinol Lett; 2014; 35 Suppl 2():158-68. PubMed ID: 25638381
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Inhibition of β-catenin signalling promotes DNA damage elicited by benzo[a]pyrene in a model of human colon cancer cells via CYP1 deregulation.
    Kabátková M; Zapletal O; Tylichová Z; Neča J; Machala M; Milcová A; Topinka J; Kozubík A; Vondráček J
    Mutagenesis; 2015 Jul; 30(4):565-76. PubMed ID: 25805023
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Evaluation of octamethylcyclotetrasiloxane (D4) as an inducer of rat hepatic microsomal cytochrome P450, UDP-glucuronosyltransferase, and epoxide hydrolase: a 28-day inhalation study.
    McKim JM; Wilga PC; Kolesar GB; Choudhuri S; Madan A; Dochterman LW; Breen JG; Parkinson A; Mast RW; Meeks RG
    Toxicol Sci; 1998 Jan; 41(1):29-41. PubMed ID: 9520339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.